» Articles » PMID: 8591889

Racial Difference in the Relationship of an Angiotensin I-converting Enzyme Gene Polymorphism to Serum Angiotensin I-converting Enzyme Activity

Overview
Journal Hypertension
Date 1996 Jan 1
PMID 8591889
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

An insertion (I)/deletion (D) polymorphism of the angiotensin I-converting enzyme (ACE) gene that has been associated with certain cardiovascular disorders accounts for nearly half the variation in serum ACE level in white subjects. Whether a similar association of serum ACE with the I/D polymorphism occurs in other racial groups is not known. We studied the I/D polymorphism of ACE in relation to serum ACE activity in 141 white and 62 black healthy, unrelated children and adolescents (mean age, 14.7 years). The mean level of ACE activity in whites homozygous for the D allele was higher than in heterozygotes (P = .002) and in homozygotes for the I allele (P = .0001), consistent with an earlier study. In blacks, on the other hand, no significant difference in serum ACE activity between genotypes was observed. An additional finding was a significantly positive relationship between serum ACE activity and diastolic pressure (P = .009). In children and adolescents, serum ACE activity is related to the ACE gene I/D polymorphism in whites but not in blacks. The results indicate a potentially important ethnic variation in genetic regulation of serum ACE activity and the relationship of the I/D polymorphism to cardiovascular disease.

Citing Articles

Association between angiotensin-converting enzyme gene insertion/deletion polymorphism and cognition impairment in patients with schizophrenia.

Mu L, Wang D, Xiu M, Zhang X Psychopharmacology (Berl). 2024; 241(12):2551-2563.

PMID: 39098876 DOI: 10.1007/s00213-024-06657-y.


The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level.

Susilo H, Pikir B, Thaha M, Alsagaff M, Suryantoro S, Kencono Wungu C Genes (Basel). 2022; 13(7).

PMID: 35885904 PMC: 9318243. DOI: 10.3390/genes13071121.


Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot.

Chakafana G, Mutithu D, Hoevelmann J, Ntusi N, Sliwa K Clin Res Cardiol. 2020; 109(12):1460-1468.

PMID: 32809116 PMC: 7433683. DOI: 10.1007/s00392-020-01720-y.


Pharmacogenomics And Hypertension: Current Insights.

Oliveira-Paula G, Pereira S, Tanus-Santos J, Lacchini R Pharmgenomics Pers Med. 2019; 12:341-359.

PMID: 31819590 PMC: 6878918. DOI: 10.2147/PGPM.S230201.


Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis.

Moe S, Long J, Schwantes-An T, Decker B, Wetherill L, Edenberg H Nephrol Dial Transplant. 2018; 34(11):1924-1931.

PMID: 29982608 PMC: 6826165. DOI: 10.1093/ndt/gfy191.